Protara Therapeutics, Inc.

Direct answer

Protara Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TARA.

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of...

Can you invest in Protara Therapeutics, Inc.?

Yes. Protara Therapeutics, Inc. trades publicly on NASDAQ as TARA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Protara Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.